Clinical Trial Update: Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection. [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of Viusid in patients with liver cirrhosis secondary to chronic hepatitis C. The study status is COMPLET…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Cirrhosis

Drugs mentioned

• Viusid

Snippet

Sponsor: Catalysis SL | Conditions: Cirrhosis, Chronic Hepatitis C | Phase 3 | Status: COMPLETED